Customize your search results with filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 02/19/2023

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 202 publications

Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial.

Condition: High-Risk Classic Hodgkin Lymphoma
Journal: The Lancet. Haematology
Treatment Used: Brentuximab Vedotin Plus Nivolumab
Number of Patients: 59
Published: November 20, 2022

Survival and prognosis analysis of patients with Hodgkin lymphoma treated with standard treatment paradigm.

Condition: Hodgkin Lymphoma (HL)
Journal: Zhonghua yi xue za zhi
Treatment Used: Standard First-Line Therapy
Number of Patients: 746
Published: November 01, 2022

Hodgkin lymphoma: 2023 update on diagnosis, risk-stratification, and management.

Condition: Hodgkin Lymphoma (HL)
Journal: American journal of hematology
Treatment Used: Chemotherapy, Stem Cell Transplantation, Radiation Therapy, and Targeted Therapies
Number of Patients: 0
Published: October 10, 2022

Treatment strategy for pediatric Hodgkin lymphoma.

Condition: Pediatric Hodgkin Lymphoma (HL)
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Treatment Used: Combination of Multiagent Chemotherapy and Low-Dose Radiation Therapy and Targeted Therapy
Number of Patients: 0
Published: October 05, 2022

HL-507 First-Line Brentuximab Vedotin Plus Chemotherapy Improves Overall Survival in Patients With Stage III/IV Classical Hodgkin Lymphoma: An Updated Analysis of ECHELON-1.

Condition: Stage III/IV Classical Hodgkin Lymphoma (cHL)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Brentuximab Vedotin Plus Chemotherapy
Published: September 27, 2022

HL-300 Efficacy of Brentuximab Vedotin Plus Conventional Chemotherapy Regimens as Pre-Autologous Stem Cell Transplantation Re-Induction Salvage Therapy in Relapsed/Refractory Classical Hodgkin Lymphoma.

Condition: Relapsed/Refractory Classical Hodgkin Lymphoma (cHL)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: Brentuximab Vedotin (BV) Plus Conventional Chemotherapy Regimens
Number of Patients: 20
Published: September 27, 2022

HL-367 ASCT for Treatment-Resistant Mediastinal Gray Zone Lymphoma.

Condition: Treatment-Resistant Mediastinal Gray Zone Lymphoma (GZL)
Journal: Clinical lymphoma, myeloma & leukemia
Treatment Used: HL-367 ASCT
Published: September 27, 2022

CD25-targeted antibody-drug conjugate camidanlumab tesirine for relapsed or refractory classical Hodgkin lymphoma.

Condition: Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (cHL)
Journal: Investigational new drugs
Treatment Used: Camidanlumab Tesirine
Number of Patients: 0
Published: September 08, 2022

Visceral leishmaniasis caused by Leishmania (Leishmania) amazonensis associated with Hodgkin's lymphoma.

Condition: Visceral Leishmaniasis (VL) in Patient with Hodgkin's Lymphoma
Journal: Revista do Instituto de Medicina Tropical de Sao Paulo
Treatment Used: Liposomal Amphotericin B and Chemotherapy
Number of Patients: 1
Published: September 08, 2022

Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study.

Condition: Refractory/Relapsed (R/R) Hodgkin Lymphoma
Journal: Leukemia & lymphoma
Treatment Used: Brentuximab Vedotin (BV) Combined with Ifosfamide-Carboplatin-Etoposide (ICE)
Number of Patients: 52
Published: August 17, 2022

Relapsed Hodgkin lymphoma with only breast involvement: a rare case report.

Condition: Relapsed Hodgkin Lymphoma
Journal: The Pan African medical journal
Treatment Used: Chemotheray
Number of Patients: 1
Published: August 01, 2022

AFM13 in patients with relapsed or refractory classical Hodgkin lymphoma: final results of an open-label, randomized, multicenter phase II trial.

Condition: Relapsed or Refractory Classical Hodgkin Lymphoma (cHL)
Journal: Leukemia & lymphoma
Treatment Used: AFM13
Number of Patients: 25
Published: July 18, 2022
Showing 1-12 of 202

Last Updated: 02/19/2023